Related Experiment Video
Updated: Sep 4, 2025
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.8K
Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and
Geoff Bates1, Rob Ralphs2, Vincent Walker Bond2
1Institute for Policy Research, University of Bath, 10 West, Claverton Down, Bath, BA2 7AY, UK.
The International Journal on Drug Policy
|July 20, 2022
Summary
Effective harm reduction strategies are crucial for image and performance enhancing drug (IPED) users. Systems mapping identified key factors contributing to IPED-related harms and prioritized interventions, including wider service provision and better community-healthcare engagement.
Area of Science:
- Public Health
- Sociology
- Drug Use Research
Background:
- Harm reduction is essential for addressing issues related to image and performance enhancing drug (IPED) use.
- Complex systems mapping offers a framework for understanding multifaceted health challenges.
Purpose of the Study:
- To apply a systems perspective to identify factors contributing to IPED-related harms in the UK.
- To determine harm reduction priorities for IPED communities.
Main Methods:
- Utilized complex systems mapping with expert stakeholders.
- Conducted two online workshops to refine a systems map and identify harm reduction priorities.
Main Results:
- Identified 51 factors contributing to IPED-related harms, categorized into nine domains.
- Highlighted four key harm reduction priorities: expanded interventions, improved community-healthcare engagement, novel information dissemination, and early intervention.
Conclusions:
- Systems mapping effectively engages stakeholders in discussing drug use.
- A comprehensive policy response is needed to address the diverse needs of IPED communities and reduce health harms.
Related Concept Videos
01:14Agonism and Antagonism: Quantification
548
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
548
01:03Drug Control Governance: Regulatory Bodies and Their Impact
239
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
239
01:15Drug Abuse and Addiction: Pharmacological Phenomena
646
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
646
01:28Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
01:19Pharmacovigilance
974
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
974
01:03Dose-Response Relationship: Overview
3.4K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.4K